SCHEMBL3572089

SCHEMBL3572089

Cc1ccccc1Cc1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 11/20 0.69
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 4/20 0.54
HPGD P15428 3/20 0.54
KMT2A Q03164 2/20 0.54
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
APEX1 P27695 1/20 0.48
DUSP3 P51452 1/20 0.48
BLM P54132 1/20 0.48
MCL1 Q07820 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MPL P40238 1/20 0.48
NR4A2 P43354 1/20 0.48
PDE4A P27815 2/20 0.46
PDE4B Q07343 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3577331 0.90 CHEK2 (0.84) CHEK2
SCHEMBL3565309 0.87 CHEK2 (0.71) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL3564131 0.85 CHEK2 (0.68) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL3569695 0.84 CHEK2 (0.67) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL3567770 0.84 CHEK2 (0.66) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL3567262 0.83 CHEK2 (0.68) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL8611783 0.82 KDM4E (0.69) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL28930292 0.82 KDM4E (0.68) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL3571326 0.81 CHEK2 (0.67) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL5176300 0.81 CHEK2 (0.64) CHEK2KDM4EALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687639-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA N.V. (BE) 2010-03-30 US disclosed
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines BW CONVERTING AB (SE) 2006-11-09 US disclosed
US-7132440-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA, N.V. (BE) 2006-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines CDKN1A, DDB1, TMBIM6 CHEK2 14/4885KDM4E 3815/4885ALDH1A1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.